Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Neoangiogenic Transcriptomic Signature Impacts Hepatocellular Carcinoma Prognosis and Can Be Triggered by Transarterial Chemoembolization Treatment.
Critelli RM, Casari F, Borghi A, Serino G, Caporali C, Magistri P, Pecchi A, Shahini E, Milosa F, Di Marco L, Pivetti A, Lasagni S, Schepis F, De Maria N, Dituri F, Martínez-Chantar ML, Di Benedetto F, Giannelli G, Villa E. Critelli RM, et al. Among authors: lasagni s. Cancers (Basel). 2024 Oct 21;16(20):3549. doi: 10.3390/cancers16203549. Cancers (Basel). 2024. PMID: 39456643 Free PMC article.
Differential Impact of Tumor Endothelial Angiopoietin-2 and Podoplanin in Lymphatic Endothelial Cells on HCC Outcomes with Tyrosine Kinase Inhibitor Treatment According to Sex.
Lasagni S, Critelli RM, Milosa F, Saltini D, Schepis F, Romanzi A, Dituri F, Serino G, Di Marco L, Pivetti A, Scianò F, Giannelli G, Villa E. Lasagni S, et al. Biomedicines. 2024 Jun 26;12(7):1424. doi: 10.3390/biomedicines12071424. Biomedicines. 2024. PMID: 39061998 Free PMC article.
The tumor microenvironment of VETC+ hepatocellular carcinoma is enriched of immunosuppressive TAMs spatially close to endothelial cells.
De Carlo C, Rosman-Nathanson R, Durante B, Akpinar R, Soldani C, Franceschini B, Lasagni S, Viganò L, Procopio F, Costa G, Torzilli G, Lleo A, Terracciano LM, Villa E, Rimassa L, Di Tommaso L. De Carlo C, et al. Among authors: lasagni s. Dig Liver Dis. 2025 Jan;57(1):62-67. doi: 10.1016/j.dld.2024.06.016. Epub 2024 Jun 29. Dig Liver Dis. 2025. PMID: 38945759
Angiopoietin-2 and the Vascular Endothelial Growth Factor Promote Migration and Invasion in Hepatocellular Carcinoma- and Intrahepatic Cholangiocarcinoma-Derived Spheroids.
Romanzi A, Milosa F, Marcelli G, Critelli RM, Lasagni S, Gigante I, Dituri F, Schepis F, Cadamuro M, Giannelli G, Fabris L, Villa E. Romanzi A, et al. Among authors: lasagni s. Biomedicines. 2023 Dec 30;12(1):87. doi: 10.3390/biomedicines12010087. Biomedicines. 2023. PMID: 38255193 Free PMC article.
GALAD outperforms aMAP and ALBI for predicting HCC in patients with compensated advanced chronic liver disease: A 12-year prospective study.
Villa E, Donghia R, Baldaccini V, Tedesco CC, Shahini E, Cozzolongo R, Ascari S, Pesole PL, Coletta S, Critelli RM, Lasagni S, Schepis F, Semellini F, Giannelli G. Villa E, et al. Among authors: lasagni s. Hepatol Commun. 2023 Sep 15;7(10):e0262. doi: 10.1097/HC9.0000000000000262. eCollection 2023 Oct 1. Hepatol Commun. 2023. PMID: 37708455 Free PMC article.
Long-Term SARS-CoV-2 Antibody Seroprevalence in Blood Donors, Italy.
Ferrari M, Di Marco L, Pivetti A, Paduano S, Vecchi C, Bernabucci V, Critelli RM, Lasagni S, De Maria M, Venturelli D, Pecorari M, Boaretto G, Serpini GF, Romagnoli D, Mantovani R, Ceccherelli GB, Villa E. Ferrari M, et al. Among authors: lasagni s. Emerg Infect Dis. 2023 Jul;29(7):1479-1481. doi: 10.3201/eid2907.221745. Epub 2023 May 30. Emerg Infect Dis. 2023. PMID: 37253276 Free PMC article.
Feasibility, safety, and outcome of second-line nivolumab/bevacizumab in liver transplant patients with recurrent hepatocellular carcinoma.
Di Marco L, Pivetti A, Foschi FG, D'Amico R, Schepis F, Caporali C, Casari F, Lasagni S, Critelli RM, Milosa F, Romanzi A, Marcelli G, De Maria N, Romagnoli D, Catellani B, Scianò F, Magistri P, Colecchia A, Sighinolfi P, Di Benedetto F, Martinez-Chantar ML, Villa E. Di Marco L, et al. Among authors: lasagni s. Liver Transpl. 2023 May 1;29(5):559-563. doi: 10.1097/LVT.0000000000000087. Epub 2023 Feb 8. Liver Transpl. 2023. PMID: 36747351 Free PMC article. No abstract available.
Upregulation of the oestrogen target gene SIX1 is associated with higher growth speed and decreased survival in HCV-positive women with hepatocellular carcinoma.
Critelli RM, Milosa F, Romanzi A, Lasagni S, Marcelli G, Di Marco L, Pivetti A, Schepis F, Romagnoli D, Mancarella S, Dituri F, Martinez-Chantar ML, Giannelli G, Villa E. Critelli RM, et al. Among authors: lasagni s. Oncol Lett. 2022 Sep 21;24(5):395. doi: 10.3892/ol.2022.13515. eCollection 2022 Nov. Oncol Lett. 2022. PMID: 36276500 Free PMC article.
Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation.
Lasagni S, Leonardi F, Pivetti A, Di Marco L, Ravaioli F, Serenari M, Gitto S, Critelli RM, Milosa F, Romanzi A, Mancarella S, Dituri F, Riefolo M, Catellani B, Magistri P, Romagnoli D, Celsa C, Enea M, de Maria N, Schepis F, Colecchia A, Cammà C, Cescon M, d'Errico A, di Benedetto F, Giannelli G, Martinez-Chantar ML, Villa E. Lasagni S, et al. Front Oncol. 2022 Sep 8;12:960808. doi: 10.3389/fonc.2022.960808. eCollection 2022. Front Oncol. 2022. PMID: 36158651 Free PMC article.
12 results